Gluta Fixative(2.5%)
Cat.No:P1128 Solarbio
Storage:Store at 2-8℃,avoid light,6 months
Qty:
Size:
{{cart_num}}
My CartStorage:Store at 2-8℃,avoid light,6 months
Qty:
Size:
Name | Gluta Fixative(2.5%) |
Storage | Store at 2-8℃,avoid light,6 months |
Delivery Time | 2-3 days |
Unit | Bottle |
Specification | 500ml |
Product Introduction:
Fixed liquids are mainly divided into aldehyde based fixed liquids, mercury based fixed liquids, alcohol based fixed liquids, oxidant based fixed liquids, picrate based fixed liquids, etc. The more commonly used are aldehyde based and alcohol based fixed liquids.
Gluta Fixative (2.5%) is mainly composed of Gluta, phosphate, etc., with a pH of 7.2-7.4. This fixative has a good fixation effect on the fine structures of the nucleus and cytoplasm, and is the most commonly used standard Gluta fixative. It is often used for the fixation of electron microscopy specimens.
Note:Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Role of liensinine in sensitivity of activated macrophages to ferroptosis and in acute liver injury
Click to check >>Author:Li Jing, Huang Qi, Lv Minling, Ma Wenfeng, Sun Jialing, Zhong Xin, Hu Rui, Ma MengQing, Han Zhiyi, Zhang Wei, Feng Wenxing, Sun Xinfeng, Zhou Xiaozhou
IF:7.0000
Publish_to:Cell Death Discovery
PMID:37353487
Brain-targeted multifunctional micelles delivering Oridonin and Phillyrin for synergistic therapy of Alzheimers disease
Click to check >>Author:Yang Yu, Si-yu He, Liang Kong, Ning-ning Shi, Yang Liu, Juan Zang, Rui-bo Guo, Lu Zhang, Xiu-ying Li, Xue-tao Li
IF:5.0000
Publish_to:JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
PMID: